- Home
- TRU vs PEN Comparison
TRU vs PEN Comparison
Compare TRU & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRU | PEN |
|---|---|---|
| Founded | 1968 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7B | 12.9B |
| IPO Year | 2013 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TRU | PEN |
|---|---|---|
| Price | $71.98 | $331.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 17 |
| Target Price | $97.10 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 2.1M | 552.5K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | 60.00 | ★ 1155.56 |
| EPS | 2.32 | ★ 4.52 |
| Revenue | ★ $4,576,300,000.00 | $1,403,665,000.00 |
| Revenue This Year | $11.14 | $14.34 |
| Revenue Next Year | $8.04 | $13.71 |
| P/E Ratio | ★ $29.31 | $72.95 |
| Revenue Growth | 9.38 | ★ 17.50 |
| 52 Week Low | $65.24 | $221.26 |
| 52 Week High | $99.39 | $362.41 |
Technical Indicators
Market Signals| Indicator | TRU | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 51.67 | 43.19 |
| Support Level | $68.23 | $326.58 |
| Resistance Level | $75.82 | $338.99 |
| Average True Range (ATR) | 3.02 | 2.14 |
| MACD | 0.47 | -0.03 |
| Stochastic Oscillator | 78.13 | 41.14 |
Price Performance
Historical ComparisonAbout TRU TransUnion
TransUnion, along with Equifax and Experian, is one of the three leading credit bureaus in the United States, providing the consumer information that is the basis for granting credit. The company also provides fraud detection, marketing, and analytical services. TransUnion operates in over 30 countries. About 20%-25% of its revenue comes from international markets.
About PEN Penumbra Inc.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.